Skip to main content
Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
21.72
+0.07 (0.32%)
Mar 31, 2025, 3:43 PM EDT - Market open

AAPG Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for AAPG.

Analyst Consensus: Buy
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

According to 1 stock analyst, the rating for AAPG is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Mar '25
Strong Buy 0
Buy 1
Hold 0
Sell 0
Strong Sell 0
Total 1

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Brian Cheng
JP Morgan
 JP Morgan
Buy
Initiates
n/a
 Buy Initiates n/a n/a Mar 27, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
950.40M
from 221.98M
Increased by 328.14%
Revenue Next Year
539.57M
from 950.40M
Decreased by -43.23%
EPS This Year
-1.10
from -3.28
EPS Next Year
-3.00
from -1.10
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
14.51M12.45M27.91M209.71M221.98M950.40M539.57M2.63B
Revenue Growth
113.21%-14.22%124.18%651.38%5.85%328.14%-43.23%386.68%
EPS
-12.69-3.14-3.07-3.35-3.28-1.10-3.003.28
EPS Growth
--------
Forward PE
-------6.62
No. Analysts -----998
Financial currency is CNY. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026202720282029
High 1.1B 625.8M 3.4B
Avg 950.4M 539.6M 2.6B
Low 639.9M 402.8M 1.5B

Revenue Growth

Revenue Growth 202420252026202720282029
High
388.8%
-34.2%
525.7%
Avg
328.1%
-43.2%
386.7%
Low
188.3%
-57.6%
174.1%

EPS Forecast

EPS 202420252026
High -0.78 -2.18 4.62
Avg -1.10 -3.00 3.28
Low -1.47 -3.92 0.61

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.